Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Behandlingsprogram vid ascites. Rekommendationer fran Svensk forening for gastroenterologi och gastrointestinal endoskopi

[Therapeutic program for ascites. Recommendations from the Swedish Society of Gastroenterology and Gastrointestinal Endoscopy]

In English

Författare

  • Lars Lööf
  • Hanne Prytz
  • Claes Söderlund
  • Sven Wallerstedt

Summary, in English

As ascites is related to liver cirrhosis in 80% of the patients, the present therapeutic guidelines are focused on ascites in liver cirrhosis. A combination of spironolactone and furosemide is recommended as first line therapy in patients with mild to moderate ascites and is effective in 90% of patients. In patients with pronounced or tense ascites, first line treatment is total paracentesis with intravenous infusion of human albumin as colloid replacement. Maintenance therapy for the prevention of recurrent ascites is based on spironolactone with or without furosemide. The indications for peritoneovenous shunt, or transjugular intrahepatic stent-shunt (TIPSS), are limited and only recommended in strictly selected patients with refractory ascites. Ascites in liver cirrhosis is a symptom of advanced liver disease, and liver transplantation should always be considered in eligible patients.

Publiceringsår

2001

Språk

Svenska

Sidor

5649-5655

Publikation/Tidskrift/Serie

Läkartidningen

Volym

98

Issue

49

Dokumenttyp

Artikel i tidskrift

Förlag

Swedish Medical Association

Ämne

  • Other Clinical Medicine

Aktiv

Published

ISBN/ISSN/Övrigt

  • ISSN: 0023-7205